Prosecution Insights
Last updated: May 29, 2026

Examiner: KENNEDY, SARAH JANE

Tech Center 1600 • Art Units: 1682

This examiner grants 0% of resolved cases

Performance Statistics

0.0%
Allow Rate
-60.0% vs TC avg
61
Total Applications
+0.0%
Interview Lift
1298
Avg Prosecution Days
Based on 8 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
0.8%
§102 Novelty
79.2%
§103 Obviousness
0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18008953 COMPOSITIONS AND METHODS FOR SEQUENCING USING AT LEAST ELECTRICAL CHARACTERISTICS Final Rejection Illumina, Inc.
18010188 Selective Addition of Reagents to Droplets Final Rejection The Regents of the University of California
17768700 COMPOSITIONS AND METHODS FOR TEMPORAL CONTROL OF CELL MODULATION Final Rejection The Regents of the University of California
17633922 COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF BLADDER CANCER Final Rejection The Regents of the University of California
18180733 ANALYTE DETECTION SYSTEMS AND METHODS OF USE Final Rejection Nautilus Subsidiary, Inc.
17594119 MARKERS OF EFFICACY OF TOPOISOMERASE POISONS Non-Final OA Northwestern University
18271793 PREDICTION OF AN OUTCOME OF A COLORECTAL CANCER SUBJECT Non-Final OA KONINKLIJKE PHILIPS N.V.
17995763 CPG-FREE ITRS FOR AAV GENE THERAPY Final Rejection THE CURATORS OF THE UNIVERSITY OF MISSOURI
18268240 METHODS OF CANCER DETECTION USING EXTRAEMBRYONICALLY METHYLATED CPG ISLANDS Non-Final OA DANA-FARBER CANCER INSTITUTE, INC.
17761040 COMPOSITIONS AND METHODS FOR TREATMENT OF A POOR PROGNOSIS SUBTYPE OF COLORECTAL CANCER Final Rejection DANA-FARBER CANCER INSTITUTE, INC.
17639532 RAPID PREDICTION OF DRUG RESPONSIVENESS Final Rejection DANA-FARBER CANCER INSTITUTE, INC.
18281068 MARKERS SPECIFIC FOR PLURIPOTENT STEM CELLS, AND METHODS OF USING THE SAME Non-Final OA FUJIFILM CELLULAR DYNAMICS, INC.
17790293 IN SITU RNA ANALYSIS USING PROBE PAIR LIGATION Final Rejection The Johns Hopkins University
17738538 CONTROLLED CROSSLINKING OF BIOMOLECUES IN SITU Non-Final OA 10x Genomics, Inc.
17986637 METHODS AND COMPOSITIONS FOR GENOTYPING AND PHENOTYPING CELLS Non-Final OA Bio-Rad Laboratories, Inc.
17801677 APPARATUS AND METHOD FOR RAPID MONITORING OF PATHOGENS IN WATER Final Rejection CRANFIELD UNIVERSITY
17606567 Digital Resolution Detection of miRNA with Single Base Selectivity by Photonic Resonator Absorption Microscopy Non-Final OA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
17907791 BIOMARKER COMPOSITION FOR DIAGNOSING DIFFUSE TYPE GASTRIC CANCER, AND MEDICAL USE THEREOF Non-Final OA AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
18183818 COMPOSITIONS AND METHODS FOR DETECTING FUSION GENES Non-Final OA Singular Genomics Systems, Inc.
17922589 METHOD AND MARKERS FOR IDENTIFICATION AND RELATIVE QUANTIFICATION OF NUCLEIC ACID SEQUENCE, MUTATION, COPY NUMBER, OR METHYLATION CHANGES USING COMBINATIONS OF NUCLEASE, LIGATION, DEAMINATION, DNA REPAIR, AND POLYMERASE REACTIONS WITH CARRYOVER PREVENTION Non-Final OA CORNELL UNIVERSITY
17691277 Methods for Predicting Treatment Response in Ulcerative Colitis Final Rejection Janssen Biotech, Inc.
17800754 SNP MOLECULAR MARKER RELATED TO SINIPERCA CHUATSI INFECTIOUS SPLEEN AND KIDNEY NECROSIS VIRUS RESISTANCE, DETECTION METHOD AND USE THEREOF Non-Final OA SOOCHOW UNIVERSITY
18481306 METHODS FOR SCREENING A SUBJECT FOR A CANCER Non-Final OA UNIVERSITE DE MONTPELLIER
18009945 METHODS FOR DETECTING AND PREDICTING CANCER AND/OR CIN3 Non-Final OA UCL Business Ltd
18017432 MCI DIAGNOSTIC MARKER, MCI DIAGNOSTIC KIT AND CORRESPONDING DETECTION METHOD Final Rejection SHANGHAI MENTAL HEALTH CENTER (SHANGHAI PSYCHOLOGICAL COUNSELLING TRAINING CENTER)
18264077 METHODS TO DETECT AND TREAT A FUNGAL INFECTION Non-Final OA THE U.S. GOVERNMENT AS REPRESENTED BY THE DEPT. OF VETERAN AFFAIRS
17403480 TAGGED-BASE DNA SEQUENCING READOUT ON WAVEGUIDE SURFACES Non-Final OA SiPhox, Inc.
17922220 TUMOR DETECTION REAGENT AND KIT Final Rejection CREATIVE BIOSCIENCES (GUANGZHOU) CO., LTD.
17800133 Method and Device for Carrying out a qPCR Process Final Rejection ROBERT BOSCH GESELLSCHAFT MIT BESCHRÄNKTER HAFTUNG
17829795 SAMPLE ANALYSIS USING ASYMMETRIC CIRCULARIZABLE PROBES Final Rejection Olga SUROVA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month